Non-trophic interactions in deserts: Facilitation, interference, and an endangered lizard speciesBASIC AND APPLIED ECOLOGYIF3.52017-05-0139PREAI
The Skin Cancer Objective Structured Clinical Examination (SCOSCE): A multi-institutional collaboration to develop and validate a clinical skills assessment for melanomaJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82015-12-016PREAI
Two contemporaneous mitogenomes from terminal Pleistocene burials in eastern BeringiaPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12015-10-2653OAAI
Inhibition of Inflammatory and Neuropathic Pain by Targeting a Mu Opioid Receptor/Chemokine Receptor5 Heteromer (MOR-CCR5)JOURNAL OF MEDICINAL CHEMISTRYIF6.82015-10-2062OAAI
Curricular Factors Associated With Medical Students' Practice of the Skin Cancer Examination An Educational Enhancement Initiative by the Integrated Skin Exam ConsortiumJAMA DERMATOLOGYIF112014-08-017PREAI
Putative Kappa Opioid Heteromers As Targets for Developing Analgesics Free of Adverse EffectsJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-07-1841OAAI
The Integrated Skin Exam film: An educational intervention to promote early detection of melanoma by medical studentsJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82014-01-0111PRE
The δ Opioid Receptor Agonist SNC80 Selectively Activates Heteromeric μ-δ Opioid ReceptorsACS CHEMICAL NEUROSCIENCEIF3.92012-05-2433OA
N-naphthoyl-β-naltrexamine (NNTA), a highly selective and potent activator of μ/κ-opioid heteromersPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12011-03-0870OAAI
A κ Opioid Pharmacophore Becomes a Spinally Selective κ-δ Agonist When Modified with a Basic Extender ArmACS MEDICINAL CHEMISTRY LETTERSIF42010-10-2715OA
Induced Association of μ Opioid (MOP) and Type 2 Cholecystokinin (CCK2) Receptors by Novel Bivalent LigandsJOURNAL OF MEDICINAL CHEMISTRYIF6.82008-12-2963OA